Therapeutic and Effective CURE-PRO Molecules for E3 Ligase-Mediated Targeted Protein Degradation.
作者信息
Kargbo Robert B
机构信息
Usona Institute, 2800 Woods Hollow Road, Fitchburg, Wisconsin 53711-5300, United States.
出版信息
ACS Med Chem Lett. 2022 Jul 21;13(8):1206-1208. doi: 10.1021/acsmedchemlett.2c00315. eCollection 2022 Aug 11.
Abstract
摘要
相似文献
1
Therapeutic and Effective CURE-PRO Molecules for E3 Ligase-Mediated Targeted Protein Degradation.
ACS Med Chem Lett. 2022 Jul 21;13(8):1206-1208. doi: 10.1021/acsmedchemlett.2c00315. eCollection 2022 Aug 11.
2
E3 ligase ligand chemistries: from building blocks to protein degraders.
Chem Soc Rev. 2022 May 10;51(9):3487-3534. doi: 10.1039/d2cs00148a.
3
Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.00225-17. Print 2017 May 1.
4
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.
ACS Chem Biol. 2019 Nov 15;14(11):2430-2440. doi: 10.1021/acschembio.8b01083. Epub 2019 May 13.
5
Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.
Mol Pharmacol. 2017 Mar;91(3):159-166. doi: 10.1124/mol.116.105569. Epub 2016 Dec 13.
6
Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation.
Cell Chem Biol. 2021 Jul 15;28(7):1014-1031. doi: 10.1016/j.chembiol.2021.04.007. Epub 2021 May 3.
7
An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs.
Methods Mol Biol. 2021;2365:135-150. doi: 10.1007/978-1-0716-1665-9_7.
8
SCF FBXW17 E3 ubiquitin ligase regulates FBXL19 stability and cell migration.
J Cell Biochem. 2021 Apr;122(3-4):326-334. doi: 10.1002/jcb.29860. Epub 2020 Oct 14.
9
A strategy to assess the cellular activity of E3 ligase components against neo-substrates using electrophilic probes.
Cell Chem Biol. 2022 Jan 20;29(1):57-66.e6. doi: 10.1016/j.chembiol.2021.08.007. Epub 2021 Sep 8.
10
Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.01578-19.
本文引用的文献
1
Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development.
J Med Chem. 2022 Apr 14;65(7):5184-5211. doi: 10.1021/acs.jmedchem.1c01835. Epub 2022 Mar 24.
2
Clinical considerations for the design of PROTACs in cancer.
Mol Cancer. 2022 Mar 7;21(1):67. doi: 10.1186/s12943-022-01535-7.
3
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.
J Med Chem. 2022 Feb 24;65(4):3066-3079. doi: 10.1021/acs.jmedchem.1c02008. Epub 2022 Feb 14.
4
PROTAC targeted protein degraders: the past is prologue.
Nat Rev Drug Discov. 2022 Mar;21(3):181-200. doi: 10.1038/s41573-021-00371-6. Epub 2022 Jan 18.
5
Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.
Med Res Rev. 2022 Mar;42(2):710-743. doi: 10.1002/med.21859. Epub 2021 Oct 11.
6
Advances in targeted therapy in non-small cell lung cancer with actionable mutations and leptomeningeal metastasis.
J Clin Pharm Ther. 2022 Jan;47(1):24-32. doi: 10.1111/jcpt.13489. Epub 2021 Jul 26.
Zotero 插件